Showing 1041-1050 of 9729 results for "".
You Want to Start A New Practice: Now What?
https://practicaldermatology.com/topics/general-topics/PD0309_12-php/22866/After making the decision to start a practice, constructing a solid business plan and financial overview is critical.Increase PA Productivity in Three Simple Steps
https://practicaldermatology.com/topics/general-topics/PD0109_03-php/22890/Hiring a qualified and talented PA is just the first step in forging a mutually rewarding, patient-focused relationship.Pigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.Enhancing Dermatopathologic Precision: Submitting Clinical Photographs with Biopsies Should Become Standard of Care in Difficult-to-Diagnose Cases
https://practicaldermatology.com/topics/editorial/enhancing-dermatopathologic-precision-submitting-clinical-photographs-with-biopsies-should-become-standard-of-care-in-difficult-to-diagnose-cases/26969/Enhancing Dermatopathologic Precision: Submitting Clinical Photographs with Biopsies Should Become Standard of Care in Difficult-to-Diagnose CasesLaser Techniques: What’s Hot
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-techniques-what-rsquo-s-hot/19146/Joel L. Cohen, MD, discusses the use of devices for fat rejuvenation techniques with Mat Avram, MD, Director of Massachusetts General Hospital Laser & Cosmetic Center in Boston. Dr. Avram describes how speaking with colleagues and doing one's homework will further assist in choosing the proper dFour Gen Z trends that dermatology practices should know
https://practicaldermatology.com/topics/practice-management/four-gen-z-trends-that-dermatology-practices-should-know/20007/As Generation Z continues to mature, their behaviors as consumers will increasingly guide how practices and other organizations appeal to them. Why not get a jumpstart? At Ekwa Marketing, we got into the heads of a generation that is increasingly exerting its influence on household buying decisionsIntegrative Approaches to Skincare: What is the Evidence?
https://practicaldermatology.com/conferences/aad-2021/integrative-approaches-to-skincare-what-is-the-evidence/19922/Alternative approaches to care may offer benefits for patients—especially when combined with conventional medical approaches. Peter Lio, MD discusses the reasons patients may turn to alternative approaches for acne, eczema, hair loss, and more. He touches on potential biases in looking at the data aMomGenes, Sernivo Approval, Industry Roundup
https://practicaldermatology.com/topics/psoriasis/dermwiretv-momgenes-sernivo-approval-industry-roundup/18613/In this edition of DermWireTV, from the editors of DermWire.com and Practical Dermatology® magazine, new research gives an up-close-and-personal view of how antiperspirant affects our microbiome. Galderma's new MomGenes campaign aims to change the way mothers and daughters talk about facial aging. TLearn More About REVIAN® Red Hair Growth System
https://practicaldermatology.com/topics/hair-nails/learn-more-about-revian-red-hair-growth-system/19750/Discover a new option for hair loss patients! REVIAN Red is a patented dual-band LED wireless cap for at-home use ten minutes daily. Click Here to Become a REVIAN Red Professional. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton clDermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of age a